Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emma Walmsley
Pharma
GSK cuts 2024 vaccines sales amid CDC's narrowed RSV policy
Despite limited RSV vaccination policy and disappointing Shingrix sales in Q2, GSK maintained Arexvy's peak sales projection and upped group guidance.
Angus Liu
Jul 31, 2024 10:13am
GSK boosts CEO Emma Walmsley's pay to £12.7M after strong year
Mar 5, 2024 2:39pm
GSK reports blockbuster sales for Arexvy in RSV race vs. Pfizer
Jan 31, 2024 9:50am
GSK pumps more than £200M into UK manufacturing network
Jan 16, 2024 10:26am
GSK CEO takes the lead in new HIV awareness campaign
May 31, 2023 9:30am
GSK CEO Emma Walmsley netted £8.45M in 2022
Mar 13, 2023 8:55am
